INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,446 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
4 sh
Jun 25, 2026
Page 623 of 1737
← PrevNext →
Jun 29, 2026
traded Jun 25, 2026
+4d
SEC Form 4

Evidence

9
AK
Agger Mette KirstineDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
23 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$63K
500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
CF
Claffee Lily FuDirector
JXNJackson Financial Inc.
Grant or award
A—
399 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BA
Borden William A.Director
SOFISoFi Technologies, Inc.
Grant or award
A—
1,016 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
GD
Goldberg Andrew D.Director
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
3,837 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VE
Vanderjagt Katherine E.VP & Chief HR Officer
LZBLA-Z-BOY INC
Tax withholding
F$22K
534 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
197 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VE
Vanderjagt Katherine E.VP & Chief HR Officer
LZBLA-Z-BOY INC
Tax withholding
F$12K
283 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
TT
Tanguler TolgaDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RV
Renda Rudolph V.Director, CO-COO AND EVP, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WA
Walia AshokChief Financial Officer
FUNSix Flags Entertainment Corporation/NEW
Grant or award
A—
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
31 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
55 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
HM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
95.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
73 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LL
Lawver Teri LSVP & Chief Commercial Officer
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
90.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
24 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
64 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LY
Lee Carol YoungVP & Chief Information Officer
LZBLA-Z-BOY INC
Tax withholding
F$14K
342 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
MB
Martin Samuel BatesSVP AND CFO
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
93.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
DJ
Dabiri JohnDirector
NVDANVIDIA CORP
Grant or award
A—
1,211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WT
Winn Walter TimothyDirector, CO-COO AND EVP
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
252 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LE
Luebke Taylor EdwardSVP and CFO
LZBLA-Z-BOY INC
Tax withholding
F$5,201
127 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
RV
Renda Rudolph V.Director, CO-COO AND EVP, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RS
Renda Frankie S.Director, PRESIDENT AND CEO, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
55.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
SP
Sudhanshu PriyadarshiCFO & President, International
PLNTPlanet Fitness, Inc.
Grant or award
A—
92.8K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
96 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
SR
Sundy Robert IIPresident, Retail
LZBLA-Z-BOY INC
Tax withholding
F$28K
683 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
8 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
TD
Torres DeniceDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
26 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LD
Lawton DrewDirector
JXNJackson Financial Inc.
Grant or award
A—
252 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
152 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LY
Lee Carol YoungVP & Chief Information Officer
LZBLA-Z-BOY INC
Tax withholding
F$7,944
194 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence